Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Regeneron

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Regeneron's Japan sales performance.

regeneron

MHRA approves second COVID-19 antibody treatment

MHRA approves second COVID-19 antibody treatment

Like Regeneron/Roche antibody cocktail Ronapreve (casirivimab/imdevimab), known as REGEN-COV in the US, Xevudy (sotrovimab) is licensed to treat people with mild to moderate COVID-19 who have at

Regeneron signs $900m cancer and infectious disease deal with Nykode

Regeneron signs $900m cancer and infectious disease deal with Nykode Along with its new name, Nykode has announced its deal with Regeneron that is worth up to $900m. ... The collaboration with Regeneron covers multiple targets across five programmes, two focused on vaccines against infectious disease and three against

EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy

EU identifies first five ‘promising’ COVID-19 drugs as part of therapeutics strategy This includes Lilly’s bamlanivimab and etesevimab combination, Roche and Regeneron’s REGEN-COV (casirivimab and imdevimab), Celltrion’s regdanivimab and GlaxoSmithKline/Vir Biotech’s sotrovimab.

US pauses shipments of Eli Lilly’s COVID-19 antibody treatment due to variant concerns

US pauses shipments of Eli Lilly’s COVID-19 antibody treatment due to variant concerns The HHS also said, however, that antibody treatments from Regeneron (REGEN-COV) and GlaxoSmithKline (GSK) and Vir Biotechnology (sotrovimab) are ‘likely’ to be effective against these variants.

Merck’s Keytruda improves outcomes for metastatic cervical cancer patients

Merck’s Keytruda improves outcomes for metastatic cervical cancer patients In March, Sanofi and Regeneron revealed positive data for their PD-1 inhibitor Libtayo (cemiplimab)  in patients previously treated with chemotherapy whose cervical cancer is recurrent or metastatic.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Havas Life Medicom

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...